(3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds

US8546375B2 · kind B2 · utility

Assignee

• ASTRAZENECA AB · SE

Inventors

• Susanne Doris Margit Bökman-Winiwarter · Timrå, SE
• Marlene Fredenwall · Timrå, SE
• Carl Anders Hogner · Mölndal, SE
• Lars Johansson · Bromma, SE
• Robert Judkins · Mölndal, SE
• Lanna Li · Timrå, SE
• Björn Christian Ingvar Löfberg · Mölndal, SE
• Sverker Von Unge

Key dates

• Filing date: Jul 5, 2011
• Grant date: Oct 1, 2013
• Expiry date: Jul 5, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein are azetidinyl compounds of formula I,as described herein, pharmaceutical compositions comprising an azetidinyl compound, and a method of using an azetidinyl compound in the treatment or prophylaxis of a melanin-concentrating hormone related disease or condition.